Big Pharma delivers another life-saving medical advance, and another demonstration of the folly of price controls.

This article explores the complex interplay between drug addiction and HIV, highlighting how integrated harm reduction ...

June 19, 2025 – The FDA has approved the first twice-yearly shot to reduce the risk of HIV infections.

The US has approved lenacapavir for HIV prevention. However, experts worry that cuts to the health budget will "squander" the drug's chance of reducing infections.

The 2025 Warren Alpert Foundation Prize has been awarded to three scientists whose discoveries culminated in the development ...

The government has granted approval to continue implementing programmes aimed at eradicating HIV/AIDS, Tuberculosis and ...

Learn more about lenacapavir, the most effective HIV treatment and prevention drug, and how its cost could cause a setback.

The FDA approved lenacapavir (Yeztugo) as pre-exposure prophylaxis (PrEP) to reduce the risk of sexually acquired HIV-1 in at ...

The US FDA has approved lenacapvir, sold under the brand name Yeztugo, as the first preventive treatment against HIV. It is a ...

Last month, the health minister said that more than half a million previously diagnosed people with HIV have been started on ...

Residents of Elgeyo Marakwet County are raising alarm over a growing shortage of condoms, a situation that has been blamed ...